1
|
Aminifard T, Razavi BM, Hosseinzadeh H. The effects of ginseng on the metabolic syndrome: An updated review. Food Sci Nutr 2021; 9:5293-5311. [PMID: 34532035 PMCID: PMC8441279 DOI: 10.1002/fsn3.2475] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2020] [Accepted: 06/30/2021] [Indexed: 12/13/2022] Open
Abstract
Metabolic syndrome is a group of risk factors including high blood glucose, dyslipidemia, high blood pressure, and high body weight. It can increase the risk of diabetes and cardiovascular disorders, which are the important reasons for death around the world. Nowadays, there are numerous demands for herbal medicine because of less harmful effects and more useful effects in comparison with chemical options. Ginseng is one of the most famous herbs used as a drug for a variety of disorders in humans. The antihyperlipidemia, antihypertension, antihyperglycemic, and anti-obesity effects of ginseng and its active constituents such as ginsenosides have been shown in different studies. In this review article, the different in vitro, in vivo, and human studies concerning the effects of ginseng and its active constituents in metabolic syndrome have been summarized. According to these studies, ginseng can control metabolic syndrome and related diseases.
Collapse
Affiliation(s)
- Tahereh Aminifard
- Department of Pharmacodynamics and ToxicologySchool of PharmacyMashhad University of Medical SciencesMashhadIran
| | - Bibi Marjan Razavi
- Department of Pharmacodynamics and ToxicologySchool of PharmacyMashhad University of Medical SciencesMashhadIran
- Targeted Drug Delivery Research CenterPharmaceutical Technology InstituteMashhad University of Medical SciencesMashhadIran
| | - Hossein Hosseinzadeh
- Department of Pharmacodynamics and ToxicologySchool of PharmacyMashhad University of Medical SciencesMashhadIran
- Pharmaceutical Research CenterPharmaceutical Technology InstituteMashhad University of Medical SciencesMashhadIran
| |
Collapse
|
2
|
Li H, Yu XH, Ou X, Ouyang XP, Tang CK. Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis. Prog Lipid Res 2021; 83:101109. [PMID: 34097928 DOI: 10.1016/j.plipres.2021.101109] [Citation(s) in RCA: 76] [Impact Index Per Article: 25.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2021] [Revised: 05/31/2021] [Accepted: 06/02/2021] [Indexed: 12/12/2022]
Abstract
Non-alcoholic fatty liver disease (NAFLD) is a quickly emerging global health problem representing the most common chronic liver disease in the world. Atherosclerotic cardiovascular disease represents the leading cause of mortality in NAFLD patients. Cholesterol metabolism has a crucial role in the pathogenesis of both NAFLD and atherosclerosis. The liver is the major organ for cholesterol metabolism. Abnormal hepatic cholesterol metabolism not only leads to NAFLD but also drives the development of atherosclerotic dyslipidemia. The cholesterol level in hepatocytes reflects the dynamic balance between endogenous synthesis, uptake, esterification, and export, a process in which cholesterol is converted to neutral cholesteryl esters either for storage in cytosolic lipid droplets or for secretion as a major constituent of plasma lipoproteins, including very-low-density lipoproteins, chylomicrons, high-density lipoproteins, and low-density lipoproteins. In this review, we describe decades of research aimed at identifying key molecules and cellular players involved in each main aspect of hepatic cholesterol metabolism. Furthermore, we summarize the recent advances regarding the biological processes of hepatic cholesterol transport and its role in NAFLD and atherosclerosis.
Collapse
Affiliation(s)
- Heng Li
- Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Hunan International Scientific and Technological Cooperation Base of Arteriosclerotic Disease, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang Medical College, University of South China, Hengyang, Hunan 421001, China
| | - Xiao-Hua Yu
- Institute of Clinical Medicine, The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan 460106, China
| | - Xiang Ou
- Department of Endocrinology, the First Hospital of Changsha, Changsha, Hunan 410005, China
| | - Xin-Ping Ouyang
- Department of Physiology, Institute of Neuroscience Research, Hengyang Key Laboratory of Neurodegeneration and Cognitive Impairment, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang Medical College, University of South China, Hengyang, Hunan 421001, China.
| | - Chao-Ke Tang
- Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Hunan International Scientific and Technological Cooperation Base of Arteriosclerotic Disease, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang Medical College, University of South China, Hengyang, Hunan 421001, China.
| |
Collapse
|
3
|
Fang H, Wei Y, Li Y, Zhou G. One-Pot Process for the Production of Ginsenoside Rd by Coupling Enzyme-Assisted Extraction with Selective Enzymolysis. Biol Pharm Bull 2020; 43:1443-1447. [PMID: 32999154 DOI: 10.1248/bpb.b19-01127] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
One-pot process for the production of ginsenoside Rd by coupling enzyme-assisted extraction with selective enzymolysis was explored in this paper. Several detection methods including HPLC-MS were used to identify and quantify the products in the enzymolysis solution of pectinase. Results showed that ginsenoside Rd was the main component in enzymolysis solution, pectinase specifically hydrolyzes protopanaxadiol (PPD)-type ginsenoside and was a selective enzyme to convert ginsenoside Rb1 to Rd in a way. In addition the influencing factors on the yield of ginsenoside Rb1 and Rd were optimized using L9(34) orthogonal design data. The enzymolysis conditions for the higher yield of Rd were 52.5 °C, pH 6 and 1 h with a yield of 0.8314 from 50 mg drug material. The controllable transformation hypothesis of the PPD-type ginsenoside was also explored from the perspective of the molecular steric hindrance. Pectinase could be used as an efficient enzyme for one-pot producing ginsenoside Rd.
Collapse
Affiliation(s)
- Haiyan Fang
- School of Biological Engineering, School of Chemical and Pharmaceutical Engineering, Qilu University of Technology (Shandong Academy of Sciences)
| | - Yingqin Wei
- School of Biological Engineering, School of Chemical and Pharmaceutical Engineering, Qilu University of Technology (Shandong Academy of Sciences)
| | - Yaqi Li
- School of Biological Engineering, School of Chemical and Pharmaceutical Engineering, Qilu University of Technology (Shandong Academy of Sciences)
| | - Guowei Zhou
- School of Biological Engineering, School of Chemical and Pharmaceutical Engineering, Qilu University of Technology (Shandong Academy of Sciences)
| |
Collapse
|
4
|
Zhao M, Yuan MM, Yuan L, Huang LL, Liao JH, Yu XL, Su C, Chen YH, Yang YY, Yu H, Xu DX. Chronic folate deficiency induces glucose and lipid metabolism disorders and subsequent cognitive dysfunction in mice. PLoS One 2018; 13:e0202910. [PMID: 30153273 PMCID: PMC6112663 DOI: 10.1371/journal.pone.0202910] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2018] [Accepted: 08/10/2018] [Indexed: 12/11/2022] Open
Abstract
Previous studies have shown that folate levels were decreased in patients with type 2 diabetes (T2D) and further lowered in T2D patients with cognitive impairment. However, whether folate deficiency could cause T2D and subsequent cognitive dysfunction is still unknown. The present study aimed to explore the effects of chronic folate deficiency (CFD) on glucose and lipid metabolism and cognitive function in mice. Seven-week-old mice were fed with either a CFD or control diet for 25 weeks. Serum folate was significantly reduced, whereas serum total homocysteine was significantly increased in the CFD group. Moreover, CFD induced obesity after a 6-week diet treatment, glucose intolerance and insulin resistance after a 16-week-diet treatment. In addition, CFD reduced the hepatic p-Akt/Akt ratio in response to acute insulin administration. Moreover, CFD increased serum triglyceride levels, upregulated hepatic Acc1 and Fasn mRNA expression, and downregulated hepatic Cd36 and ApoB mRNA expression. After a 24-week diet treatment, CFD induced anxiety-related activities and impairment of spatial learning and memory performance. This study demonstrates that folate deficiency could induce obesity, glucose and lipid metabolism disorders and subsequent cognitive dysfunction.
Collapse
Affiliation(s)
- Mei Zhao
- School of Nursing, Anhui Medical University, Hefei, China
- Anhui Provincial Key Laboratory of Population Health & Aristogenics, Hefei, China
| | - Man Man Yuan
- School of Nursing, Anhui Medical University, Hefei, China
| | - Li Yuan
- School of Nursing, Anhui Medical University, Hefei, China
| | - Li Li Huang
- School of Nursing, Anhui Medical University, Hefei, China
| | - Jian Hong Liao
- School of Nursing, Anhui Medical University, Hefei, China
| | - Xiao Ling Yu
- School of Nursing, Anhui Medical University, Hefei, China
| | - Chang Su
- School of Nursing, Anhui Medical University, Hefei, China
| | - Yuan Hua Chen
- Anhui Provincial Key Laboratory of Population Health & Aristogenics, Hefei, China
- Department of Histology and Embryology, Anhui Medical University, Hefei, China
| | - Yu Ying Yang
- School of Nursing, Anhui Medical University, Hefei, China
| | - Huan Yu
- School of Nursing, Anhui Medical University, Hefei, China
| | - De Xiang Xu
- Anhui Provincial Key Laboratory of Population Health & Aristogenics, Hefei, China
- Department of Toxicology, Anhui Medical University, Hefei, China
| |
Collapse
|
5
|
Han JS, Sung JH, Lee SK. Inhibition of Cholesterol Synthesis in HepG2 Cells by GINST-Decreasing HMG-CoA Reductase Expression Via AMP-Activated Protein Kinase. J Food Sci 2017; 82:2700-2705. [DOI: 10.1111/1750-3841.13828] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2016] [Revised: 06/16/2017] [Accepted: 06/30/2017] [Indexed: 12/27/2022]
Affiliation(s)
- Joon-Seung Han
- BioTech Research Laboratory; Central Research Inst.; Ilhwa Co., Ltd. Gangdong-gu Seoul 05288 Republic of Korea
| | - Jong Hwan Sung
- BioTech Research Laboratory; Central Research Inst.; Ilhwa Co., Ltd. Gangdong-gu Seoul 05288 Republic of Korea
| | - Seung Kwon Lee
- BioTech Research Laboratory; Central Research Inst.; Ilhwa Co., Ltd. Gangdong-gu Seoul 05288 Republic of Korea
| |
Collapse
|
6
|
Abstract
Although ginseng has been shown to have an antiobesity effect, antiobesity-related mechanisms are complex and have not been completely elucidated. In the present study, we evaluated ginseng’s effects on food intake, the digestion, and absorption systems, as well as liver, adipose tissue, and skeletal muscle in order to identify the mechanisms involved. A review of previous in vitro and in vivo studies revealed that ginseng and ginsenosides can increase energy expenditure by stimulating the adenosine monophosphate-activated kinase pathway and can reduce energy intake. Moreover, in high fat diet-induced obese and diabetic individuals, ginseng has shown a two-way adjustment effect on adipogenesis. Nevertheless, most of the previous studies into antiobesity effects of ginseng have been animal based, and there is a paucity of evidence supporting the suggestion that ginseng can exert an antiobesity effect in humans.
Collapse
|
7
|
Qiang G, Hengyao Z, Mindian L, Ziyi Z, Yunlin L, Yulei L, Wenzhai C, Huan Z, Ranran Z, Xingxing L, Huizhen C, Huakui G, Zhihuang Z, Qi C, Cuimei S, Xinli Z, Jian G, Sen Z, Qiu C. Efficacy and safety of Sancai powder in patients with type 2 diabetes mellitus: a randomized controlled trial. J TRADIT CHIN MED 2016; 36:640-8. [DOI: 10.1016/s0254-6272(16)30084-x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
8
|
Ganesan P, Ko HM, Kim IS, Choi DK. Recent trends of nano bioactive compounds from ginseng for its possible preventive role in chronic disease models. RSC Adv 2015. [DOI: 10.1039/c5ra20559j] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023] Open
Abstract
Bioactive nano ginseng has roles in various diseases.
Collapse
Affiliation(s)
- Palanivel Ganesan
- Nanotechnology Research Center and Department of Applied Life Science
- College of Biomedical and Health Science
- Konkuk University
- Chungju 380-701
- Republic of Korea
| | - Hyun-Myung Ko
- Department of Biotechnology
- College of Biomedical and Health Science
- Konkuk University
- Chungju 380-701
- Republic of Korea
| | - In-Su Kim
- Department of Biotechnology
- College of Biomedical and Health Science
- Konkuk University
- Chungju 380-701
- Republic of Korea
| | - Dong-Kug Choi
- Nanotechnology Research Center and Department of Applied Life Science
- College of Biomedical and Health Science
- Konkuk University
- Chungju 380-701
- Republic of Korea
| |
Collapse
|
9
|
Park SH, Oh MR, Choi EK, Kim MG, Ha KC, Lee SK, Kim YG, Park BH, Kim DS, Chae SW. An 8-wk, randomized, double-blind, placebo-controlled clinical trial for the antidiabetic effects of hydrolyzed ginseng extract. J Ginseng Res 2014; 38:239-43. [PMID: 25379002 PMCID: PMC4213818 DOI: 10.1016/j.jgr.2014.05.006] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2014] [Revised: 04/30/2014] [Accepted: 05/11/2014] [Indexed: 11/30/2022] Open
Abstract
BACKGROUND To investigate the antidiabetic effects of hydrolyzed ginseng extract (HGE) for Korean participants in an 8-wk, randomized, double-blinded, placebo-controlled clinical trial. METHODS Impaired fasting glucose participants [fasting plasma glucose (FPG) ≥ 5.6mM or < 6.9mM] who had not been diagnosed with any disease and met the inclusion criteria were recruited for this study. The 23 participants were randomly divided into either the HGE (n = 12, 960 mg/d) or placebo (n = 11) group. Outcomes included measurements of efficacy (FPG, postprandial glucose, fasting plasma insulin, postprandial insulin, homeostatic model assessment-insulin resistance, and homeostatic model assessment-β) and safety (adverse events, laboratory tests, electrocardiogram, and vital signs). RESULTS After 8 wk of HGE supplementation, FPG and postprandial glucose were significantly decreased in the HGE group compared to the placebo group. No clinically significant changes in any safety parameter were observed. Our study revealed that HGE is a potent antidiabetic agent that does not produce noticeable adverse effects. CONCLUSION HGE supplementation may be effective for treating impaired fasting glucose individuals.
Collapse
Affiliation(s)
- Soo-Hyun Park
- Clinical Trial Center for Functional Foods, Chonbuk National University Hospital, 20 Geonji-ro, Deokjin-gu, Jeonju, Jeonbuk, Korea
| | - Mi-Ra Oh
- Clinical Trial Center for Functional Foods, Chonbuk National University Hospital, 20 Geonji-ro, Deokjin-gu, Jeonju, Jeonbuk, Korea
| | - Eun-Kyung Choi
- Clinical Trial Center for Functional Foods, Chonbuk National University Hospital, 20 Geonji-ro, Deokjin-gu, Jeonju, Jeonbuk, Korea
| | - Min-Gul Kim
- Clinical Trial Center, Chonbuk National University Hospital, 20 Geonji-ro, Deokjin-gu, Jeonju, Jeonbuk, Korea
| | - Ki-Chan Ha
- Healthcare Claims and Management Incorporation, 758 Baekje-daero, Deokjin-gu, Jeonju, Jeonbuk, Korea
| | - Seung-Kwon Lee
- Central Research Center, Ilhwa Co., Ltd., 25, Angol-ro, 56Beon-gil, Guri, Gyeonggi, Korea
| | - Young-Gon Kim
- Department of Urology, Chonbuk National University Medical School, 567 Baekje-daero, Deokjin-gu, Jeonju, Jeonbuk, Korea
| | - Byung-Hyun Park
- Department of Biochemistry, Chonbuk National University Medical School, 567 Baekje-daero, Deokjin-gu, Jeonju, Jeonbuk, Korea
| | - Dal-Sik Kim
- Department of Laboratory Medicine, Chonbuk National University Medical School, 567 Baekje-daero, Deokjin-gu, Jeonju, Jeonbuk, Korea
| | - Soo-Wan Chae
- Clinical Trial Center for Functional Foods, Chonbuk National University Hospital, 20 Geonji-ro, Deokjin-gu, Jeonju, Jeonbuk, Korea ; Clinical Trial Center, Chonbuk National University Hospital, 20 Geonji-ro, Deokjin-gu, Jeonju, Jeonbuk, Korea ; Department of Pharmacology, Chonbuk National University Medical School, 567 Baekje-daero, Deokjin-gu, Jeonju, Jeonbuk, Korea
| |
Collapse
|
10
|
Eddouks M, Bidi A, El Bouhali B, Hajji L, Zeggwagh NA. Antidiabetic plants improving insulin sensitivity. ACTA ACUST UNITED AC 2014; 66:1197-214. [PMID: 24730446 DOI: 10.1111/jphp.12243] [Citation(s) in RCA: 56] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2013] [Accepted: 02/23/2014] [Indexed: 12/19/2022]
Abstract
BACKGROUND Globally, the prevalence of diabetes mellitus is increasing at an alarming rate. This chronic pathology gravely troubled the human health and quality of life. Both insulin deficiency and insulin resistance are involved in the pathophysiology of diabetes mellitus. Moreover, insulin resistance is being diagnosed nowadays in a growing population of diabetic and obese patients, especially in industrialized societies. There are lots of conventional agents available to control and to treat diabetes, but total recovery from this disorder has not been reported up to this date. Plants provided a potential source of hypoglycemic drugs and are widely used in several traditional systems of medicine to prevent diabetes. A few reviews with less attention paid to mechanisms of action have been published on antidiabetic plants. OBJECTIVES The present review focuses on the various plants that have been reported to be effective in improving insulin sensitivity associated with diabetes. KEY FINDINGS In this work, an updated systematic review of the published literature has been conducted to review the antidiabetic plants improving insulin sensitivity and 111 medicinal plants have been reported to have a beneficial effect on insulin sensitivity using several in-vitro and in-vivo animal models of diabetes. CONCLUSION The different metabolic and cellular effects of the antidiabetic plants improving insulin sensitivity are reported indicating the important role of medicinal plants as potential alternative or complementary use in controlling insulin resistance associated with diabetes mellitus.
Collapse
Affiliation(s)
- Mohamed Eddouks
- Faculty of Sciences and Techniques Errachidia, Moulay Ismail University, Errachidia, Morocco
| | | | | | | | | |
Collapse
|